Esperion Therapeutics | ESPR - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -3.27B 628M 2025-12
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amarin USD 449.41M 9.87M 2026-03
Amgen USD 9.19B 532M 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Cipla INR 329.19B 16.3B 2025-09
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -826.57M 166.94M 2026-03
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Geron USD 225.87M 22.83M 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Merck USD 45.88B 6.73B 2026-03
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Moderna USD 7.41B 1.24B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Pfizer USD 90.1B 3.63B 2026-03
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sanofi EUR 72.81B 1.1B 2026-03
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12